SEGMENT AND RELATED INFORMATION (Tables)

12 Months Ended

Dec. 31, 2016

SEGMENT AND RELATED INFORMATION

Summary of financial information concerning the Company's operating segments

(in thousands)	Patient Care		Products & Services			Corporate & Other			Consolidating Adjustments			Total
2016
Net revenue
Third party	$	840,130	$	201,924		$	—		$	—		$	1,042,054
Intersegments	—		175,539			—			(175,539		)	—
Total net revenue	840,130		377,463			—			(175,539		)	1,042,054
Material costs
Third party suppliers	230,957		101,114			—			—			332,071
Intersegments	25,055		150,484			—			(175,539		)	—
Total material costs	256,012		251,598			—			(175,539		)	332,071
Personnel costs	315,892		47,645			—			—			363,537
Other expenses	150,604		32,228			104,649			—			287,481
Depreciation & amortization	24,873		11,600			8,414			—			44,887
Impairment of intangible assets	—		86,164			—			—			86,164
Income (loss) from operations	92,749		(51,772		)	(113,063		)	—			(72,086		)
Interest expense (income), net	33,081		13,097			(979		)	—			45,199
Extinguishment of debt	—		—			6,031			—			6,031
Income (loss) from continuing operations before income taxes	59,668		(64,869		)	(118,115		)	—			(123,316		)
Benefit for income taxes	—		—			(15,910		)	—			(15,910		)
Income (loss) from continuing operations	$	59,668	$	(64,869	)	$	(102,205	)	$	—		$	(107,406	)
EBITDA	$	117,622	$	(40,172	)	$	(104,649	)	$	—		$	(27,199	)
Total assets	419,895		159,354			175,855			—			755,104
Capital expenditures	14,581		820			5,747			—			21,148

(in thousands)	Patient Care			Products & Services		Corporate & Other			Consolidating Adjustments			Total
2015
Net revenue
Third party	$	874,960		$	192,212	$	—		$	—		$	1,067,172
Intersegments	—			137,282		—			(137,282		)	—
Total net revenue	874,960			329,494		—			(137,282		)	1,067,172
Material costs
Third party suppliers	242,714			93,569		—			—			336,283
Intersegments	19,613			117,669		—			(137,282		)	—
Total material costs	262,327			211,238		—			(137,282		)	336,283
Personnel costs	317,927			49,167		—			—			367,094
Other expenses	163,240			25,487		92,520			—			281,247
Depreciation and amortization	25,674			11,883		8,786			—			46,343
Impairment of intangible assets	382,860			2,947								385,807
(Loss) income from operations	(277,068		)	28,772		(101,306		)	—			(349,602		)
Interest expense (income), net	33,677			13,114		(16,899		)	—			29,892
Extinguishment of debt	—			—		7,237			—			7,237
(Loss) income from continuing operations before income taxes	(310,745		)	15,658		(91,644		)	—			(386,731		)
Benefit for income taxes	—			—		(67,614		)	—			(67,614		)
(Loss) income from continuing operations	$	(310,745	)	$	15,658	$	(24,030	)	$	—		$	(319,117	)
EBITDA	$	(251,394	)	$	40,655	$	(92,520	)	$	—		$	(303,259	)
Total assets	468,575			257,640		246,869			—			973,084
Capital expenditures	16,505			2,937		8,178			—			27,620

(in thousands)	Patient Care		Products & Services		Corporate & Other			Consolidating Adjustments			Total
2014
Net revenue
Third party	$	837,080	$	175,020	$	—		$	—		$	1,012,100
Intersegments	—		162,636		—			(162,636		)	—
Total net revenue	837,080		337,656		—			(162,636		)	1,012,100
Material costs
Third party suppliers	240,685		83,599		—			—			324,284
Intersegments	19,587		143,049		—			(162,636		)	—
Total material costs	260,272		226,648		—			(162,636		)	324,284
Personnel costs	305,651		47,935		—			—			353,586
Other expenses	152,176		27,498		88,124			—			267,798
Depreciation and amortization	18,769		12,022		8,138			—			38,929
Impairment of intangible assets	—		223		—			—			223
Income (loss) from operations	100,212		23,330		(96,262		)	—			27,280
Interest expense (income), net	33,465		13,079		(18,267		)	—			28,277
Income (loss) from continuing operations before income taxes	66,747		10,251		(77,995		)	—			(997		)
Provision for income taxes	—		—		2,023			—			2,023
Income (loss) from continuing operations	$	66,747	$	10,251	$	(80,018	)	$	—		$	(3,020	)
EBITDA	$	118,981	$	35,352	$	(88,124	)	$	—		$	66,209
Total assets	848,092		262,721		124,920			—			1,235,733
Capital expenditures	14,067		1,305		11,724			—			27,096